81 related articles for article (PubMed ID: 17565746)
1. Prospective study of urinary excretion of 7-methylguanine and the risk of lung cancer: Effect modification by mu class glutathione-S-transferases.
Loft S; Svoboda P; Kasai H; Tjønneland A; Møller P; Sørensen M; Overvad K; Autrup H; Raaschou-Nielsen O
Int J Cancer; 2007 Oct; 121(7):1579-84. PubMed ID: 17565746
[TBL] [Abstract][Full Text] [Related]
2. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
3. Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study.
Loft S; Svoboda P; Kawai K; Kasai H; Sørensen M; Tjønneland A; Vogel U; Møller P; Overvad K; Raaschou-Nielsen O
Free Radic Biol Med; 2012 Jan; 52(1):167-72. PubMed ID: 22044660
[TBL] [Abstract][Full Text] [Related]
4. Modification of urinary N7-methylguanine excretion in smokers by glutathione-S-transferase M1 polymorphism.
Lin IH; Chao MR; Hu CW; Ho ML; Huang JY; Lee HS; Chen CC; Wong RH
Toxicology; 2009 Jun; 260(1-3):1-6. PubMed ID: 19464563
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer.
Sørensen M; Autrup H; Tjønneland A; Overvad K; Raaschou-Nielsen O
Int J Cancer; 2004 Jun; 110(2):219-24. PubMed ID: 15069685
[TBL] [Abstract][Full Text] [Related]
6. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
9. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
[TBL] [Abstract][Full Text] [Related]
11. Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers.
Woodson K; Stewart C; Barrett M; Bhat NK; Virtamo J; Taylor PR; Albanes D
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):965-70. PubMed ID: 10566550
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
[TBL] [Abstract][Full Text] [Related]
14. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk.
Spitz MR; Duphorne CM; Detry MA; Pillow PC; Amos CI; Lei L; de Andrade M; Gu X; Hong WK; Wu X
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1017-20. PubMed ID: 11045782
[TBL] [Abstract][Full Text] [Related]
15. Interactions between GSTM1, GSTT1 and GSTP1 polymorphisms and smoking and intake of fruit and vegetables in relation to lung cancer.
Sørensen M; Raaschou-Nielsen O; Brasch-Andersen C; Tjønneland A; Overvad K; Autrup H
Lung Cancer; 2007 Feb; 55(2):137-44. PubMed ID: 17123660
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk.
Jourenkova-Mironova N; Voho A; Bouchardy C; Wikman H; Dayer P; Benhamou S; Hirvonen A
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):185-8. PubMed ID: 10067818
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
Safarinejad MR; Shafiei N; Safarinejad SH
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer.
Loft S; Svoboda P; Kasai H; Tjønneland A; Vogel U; Møller P; Overvad K; Raaschou-Nielsen O
Carcinogenesis; 2006 Jun; 27(6):1245-50. PubMed ID: 16364924
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
